ValiRx Share Price | |
---|---|
Price | 3.30 |
Bid | 3.20 |
Ask | 3.40 |
Change | -0.15 (-4.35%) |
Volume | 607,805 |
Open | 3.45 |
High | 3.45 |
Low | 3.25 |
Prev. Close | 3.45 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 132.35m |
Market Capitalisation | £4.37m |
Market Size | 15,000 |
52 Week High | 14.75 |
52 Week High Date | 03-Nov-2023 |
52 Week Low | 3.25 |
52 Week Low Date | 25-Apr-2024 |
# Trades | 19 |
---|---|
Vol. Sold | 129,232 |
Sold Value | £4.25k |
Vol. Bought | 393,573 |
Bought Value | £13.01k |
PE Ratio | -1.078431 |
Earnings | -3.06 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
25-Apr-24 | 16:13:41 | 3.30 | 85,000 | Unknown* | 3.20 | 3.40 | 2,805 | O Ordinary |
25-Apr-24 | 16:13:27 | 3.30 | 25,000 | Buy* | 3.20 | 3.30 | 825.00 | O Ordinary |
25-Apr-24 | 15:15:41 | 3.30 | 1,837 | Buy* | 3.20 | 3.30 | 60.62 | O Ordinary |
25-Apr-24 | 14:02:09 | 3.30 | 25,000 | Buy* | 3.20 | 3.30 | 825.00 | O Ordinary |
25-Apr-24 | 13:58:00 | 3.30 | 30,000 | Buy* | 3.20 | 3.30 | 990.00 | O Ordinary |
25-Apr-24 | 13:55:10 | 3.24 | 8,322 | Sell* | 3.20 | 3.30 | 269.63 | O Ordinary |
25-Apr-24 | 13:52:11 | 3.236 | 1,423 | Sell* | 3.20 | 3.30 | 46.05 | O Ordinary |
25-Apr-24 | 12:45:40 | 3.30 | 15,045 | Buy* | 3.20 | 3.30 | 496.49 | O Ordinary |
25-Apr-24 | 12:23:11 | 3.225 | 298 | Sell* | 3.20 | 3.30 | 9.61 | O Ordinary |
25-Apr-24 | 12:20:12 | 3.298 | 5,000 | Buy* | 3.20 | 3.30 | 164.90 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Jul-22 | 07-Jul-22 | Placing | Gerald Desler held the position of CFO at the time of this trade.Gerald Desler | 10.00 | GBX | 25,000 | 128,668 |
07-Jul-22 | 07-Jul-22 | Placing | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 10.00 | GBX | 100,000 | 372,333 |
07-Jul-22 | 07-Jul-22 | Placing | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 10.00 | GBX | 100,000 | 144,000 |
07-Jul-22 | 07-Jul-22 | Placing | Suzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly | 10.00 | GBX | 100,000 | 416,668 |
18-Feb-21 | 17-Feb-21 | Buy | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 22.25 | GBX | 22,000 | 272,333 |
Click here to read more about our shareholder information - providing intellectual, corporate and financial support in the early stages of drug development.